Karyopharm Therapeutics | KPTI - Funcionários Número total





Funcionários Alterar Data
AbbVie 55K 5K 2024-12
Abbott 114K 1000 2023-12
Amgen 28K 1.3K 2024-12
AstraZeneca USD 89.9K 6.4K 2023-12
BioCryst Pharmaceuticals 536 5 2023-12
Bristol-Myers Squibb 34.1K 0 2024-12
Eli Lilly 47K 4K 2024-12
Enanta Pharmaceuticals 145 15 2023-09
GlaxoSmithKline 69.4K 20.7K 2022-12
Incyte 2.62K 93 2024-12
J&J 138.1K 6.2K 2024-12
Karyopharm Therapeutics 325 60 2023-12
MacroGenics 339 18 2023-12
Merck 75K 3K 2024-12
Nektar Therapeutics 137 79 2023-12
Novartis USD 101.7K 2.62K 2022-12
Novartis 101.7K 2.62K 2022-12
Pfizer 81K 7K 2024-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sangamo BioSciences 405 73 2023-12
Takeda 47.46K 1.83K 2025-12
Tectonic Therapeutic 45 1 2023-12
TG Therapeutics 338 74 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Xencor 250 30 2024-12